The results were consistent with previous studies: a low CD8 T cells score was associated with poorer survival in triple-negative breast cancer (23); Breast cancer patients with low DC count tended to have shorter progression-free survival than patients with high infiltrated DC (24). The gene discussed is CD8A; the disease is triple-negative breast carcinoma.